SEARCH
Experimental Alzheimer's drug slows cognitive decline in trial, firms say - 1breakingnews.com
1BN-RADIO
2022-09-28
Views
7
Description
Share / Embed
Download This Video
Report
Makers of the drug have already applied to the Food and Drug Administration for accelerated approval for lecanemab, based on earlier-stage data.
VIEW MORE : https://bit.ly/1breakingnews
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x8e1kk9" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
00:40
Biogen And Eisai To Move Forward With Alzheimer's Research
00:23
New Alzheimer's Drug From Biogen and Eisai Is Just the Beginning - 1breakingnews.com
05:11
In a medical first, new experimental Alzheimer's treatment 'slows cognitive decline'
05:25
Experimental Alzheimer's treatment slows cognitive decline, 'but it doesn't stop' the disease
01:00
El nuevo fármaco de Biogen y Eisai frena el deterioro cognitivo producido por alzhéimer
02:00
Biogen to ship Alzheimer's drug in two weeks
00:33
104952-mainHouse investigation faults FDA, Biogen for Alzheimer's drug approval - 1breakingnews.com
01:54
Biogen stock increases as Alzheimer's drug shows promise in early results of study - 1breakingnews.c
02:14
Biogen shares soar on Alzheimer's drug developments - 1breakingnews.com
03:10
Biogen Stock Rockets To Record High On Alzheimer's Drug Approval; 5
02:00
Biogen to ship Alzheimer's drug in two weeks
02:17
Biogen Plunges After FDA Says No to Alzheimer's Treatment
